- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/47 - One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
Patent holdings for IPC class C07D 239/47
Total number of patents in this class: 725
10-year publication summary
|
76
|
50
|
52
|
50
|
41
|
36
|
34
|
24
|
23
|
34
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ADAMA Makhteshim Ltd. | 531 |
41 |
| Bristol-myers Squibb Company | 4826 |
25 |
| Novartis AG | 10612 |
18 |
| Oxular Acquisitions Limited | 21 |
14 |
| Boehringer Ingelheim International GmbH | 4636 |
13 |
| Corteva Agriscience LLC | 2702 |
12 |
| Carnegie Mellon University | 1581 |
11 |
| Genentech, Inc. | 4016 |
8 |
| Celgene Quanticel Research, Inc. | 162 |
8 |
| Curza Global, LLC | 29 |
8 |
| Eli Lilly and Company | 3926 |
8 |
| Emergent BioDefense Operations Lansing LLC | 29 |
8 |
| Shionogi & Co., Ltd. | 836 |
8 |
| University of Utah Research Foundation | 1840 |
8 |
| Merck Patent GmbH | 5752 |
7 |
| Actelion Pharmaceuticals Ltd | 528 |
7 |
| Kowa Company, Ltd. | 1211 |
7 |
| Ono Pharmaceutical Co., Ltd. | 428 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2626 |
6 |
| Ocuphire Pharma, Inc. | 22 |
6 |
| Other owners | 495 |